Multicenter, Controlled, Randomized, Safety and Pharmacokinetic Study Comparing Intracisternal EG-1962 to Standard of Care Enteral Nimodipine in Adults With Aneurysmal Subarachnoid Hemorrhage
Phase of Trial: Phase I
Latest Information Update: 09 Mar 2018
At a glance
- Drugs Nimodipine (Primary) ; Nimodipine (Primary)
- Indications Aneurysm; Subarachnoid haemorrhage
- Focus Adverse reactions
- Sponsors Edge Therapeutics
- 28 Feb 2018 Planned End Date changed from 1 Feb 2018 to 1 Mar 2019.
- 28 Feb 2018 Planned primary completion date changed from 1 Feb 2018 to 1 Mar 2019.
- 13 Mar 2017 According to an Edge Therapeutics media release, first patient has been randomized in this trial. Nerissa U. Ko is investigator of this study. Company expects data from this study in 2017.